D. Keith Grossman

(Mr. D. Keith Grossman)

Currently holds positions in Outset Medical Inc, ViewRay Inc, Bayer Essure Inc and Alcon AG

Positions

Position Company Period
Chairman of the Board Outset Medical Inc None -
Independent Director ViewRay Inc July 1, 2018 -
President, Chief Executive Officer Bayer Essure Inc June 5, 2013 -
Vice Chairman of the Board, Senior Independent Director Alcon AG None -
Lead Independent Director ZELTIQ Aesthetics Inc Feb. 1, 2016 - April 28, 2017
Independent Director ZELTIQ Aesthetics Inc Oct. 24, 2013 - Feb. 1, 2016
President, Chief Executive Officer, Director Thoratec Corp Sept. 22, 2014 - Oct. 8, 2015
Independent Director Thoratec Corp Jan. 17, 2006 - Sept. 22, 2014
President, Chief Executive Officer, Director Bayer Essure Inc Dec. 8, 2011 - June 5, 2013
D. Keith Grossman's trades of Nevro Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-03 2024-06-03
PS Planned sale
11,887 -13.8%
3.74
USD 44,468 		11,887 -13.8% 3.74 USD 44,468
2024-06-03 2024-06-03
PS Planned sale
26,230 -35.4%
3.80
USD 99,766 		26,230 -35.4% 3.80 USD 99,766
2022-03-08 2022-03-08
US Nevro Corp (NVRO)
B Purchase
3,200 +1.9%
63.59
USD 203,488 		3,200 +1.9% 63.59 USD 203,488
2021-12-02 2021-12-01
PS Planned sale
1,296 -20.0%
47.92
USD 62,104 		1,296 -20.0% 47.92 USD 62,104
2021-11-02 2021-11-01
PS Planned sale
1,296 -16.7%
54.31
USD 70,386 		1,296 -16.7% 54.31 USD 70,386
2021-11-02 2021-11-01
PS Planned sale
2,592 -25.0%
55.00
USD 142,560 		2,592 -25.0% 55.00 USD 142,560
2021-10-04 2021-10-01
PS Planned sale
1,234 -37.5%
49.69
USD 61,317 		1,234 -37.5% 49.69 USD 61,317
2021-10-04 2021-10-01
PS Planned sale
62 -1.9%
49.69
USD 3,081 		62 -1.9% 49.69 USD 3,081
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
USD 71,280 		1,296 -28.3% 55.00 USD 71,280
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
USD 71,280 		1,296 -28.3% 55.00 USD 71,280
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
USD 71,280 		1,296 -28.3% 55.00 USD 71,280
2021-10-04 2021-09-17
PS Planned sale
1,296 -28.3%
55.00
USD 71,280 		1,296 -28.3% 55.00 USD 71,280
2021-08-17 2021-08-13
US Nevro Corp (NVRO)
B Purchase
7,000 +5.9%
105.07
USD 735,490 		7,000 +5.9% 105.07 USD 735,490
2021-06-02 2021-06-01
PS Planned sale
1,296 -100.0%
47.92
USD 62,102 		1,296 -100.0% 47.92 USD 62,102
// ... existing code ... // ... rest of the file ...